EVALUATION OF EFFICIENCY AND SAFETY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Protsenko G.O. Dubas V.V. Дата: 2022-06-15 / Review: 11
Nintedanib: highly specialized medical care for fibrosing interstitial lung diseases
Author:Lukianchuk Evheniia №87 (1) 2022 / Review: 10
UNCONTROLLED GOUT AS A POSSIBLE CAUSE OF COMORBIDITY AND A RISK FACTOR FOR A SEVERE COVID-19 COURSE
Authors: Smiyan S.I. Makhovska O.Yu. №87 (1) 2022 / Review: 14
Choosing the optimal urate-lowering therapy for patients with gout
Author:The editors of the «Ukrainian rheumatological journal» №87 (1) 2022 / Review: 12
THE CURRENT ISSUES OF OBSERVATION OF CHILDREN WITH RHEUMATIC DISEASES
Author:Oshlianska O.A. №87 (1) 2022 / Review: 33
PHARMACOTHERAPY OF DISEASES OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH RISK OF COVID-19-ASSOCIATED THROMBOINFLAMMATION
Authors: Rekalov D.H. Golovach I.Yu. Kostenko V.O.  Shevchenko M.V.... №87 (1) 2022 / Review: 24
Survival analysis of patients with pulmonary arterial hypertension associated with connective tissue disease
Authors: Sirenko Yu.M. Radchenko G.D. Garmish O.O. Deiak S.I.... №87 (1) 2022 / Review: 16
Analysis of risk factors for the development of disorders of bone mineral density in patients with axial spondyloarthritis
Authors: Bortkevych O. Sytenko A. №87 (1) 2022 / Review: 14
ANALYSIS OF DELAYING THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Protsenko G.O. Dubas V.V. №87 (1) 2022 / Review: 10
THE USE OF NSAIDS IN CHRONIC KIDNEY DISEASE: FEASIBILITY AND SAFETY PROFILE MANAGEMENT
Author:Yehudina Ye.D. №86 (4) 2021 / Review: 13
DIFFERENTIATED APPROACH TO URATE-LOWERING THERAPY OF GOUT DEPENDING ON AGE, SEX AND COMORBIDITIES
Authors: Krylova A.S. Dubkova A.G. Tsymbaliuk T.S. №86 (4) 2021 / Review: 10
EXPERIENCE OF USING NABUMETONE IN PATIENTS WITH REACTIVE ARTHRITIS
Authors: Protsenko G.O. Pasternak M.L. №86 (4) 2021 / Review: 16
PURIN METABOLISM DISORDERS AND INTESTINAL MICROBIOTA
Authors: Koval S. Snigurska I. Bozhko V.V. Miloslavsky D.... №86 (4) 2021 / Review: 10
JUVENILE DERMATOMYOSITIS. WHAT SHOULD AN ADULT RHEUMATOLOGIST REMEMBER?
Authors: Oshlianska O.A. Shevchenko N.S. Biliavska Iu.V. №86 (4) 2021 / Review: 14
IMMUNOGENETIC CHARACTERISTICS OF THE HLA SYSTEM IN PATIENTS WITH EARLY AND LATE CHD AND PERMANENT MYOCARDIAL INFARCTION
Authors: Lomakovsky A.N. Minchenko J.N. Gavrilenko T.I. Pidgaina O.A. №86 (4) 2021 / Review: 20

12345...10...Последняя »